Analysts Set The Joint Corp. (NASDAQ:JYNT) Price Target at $22.00

The Joint Corp. (NASDAQ:JYNT) has received an average rating of “Moderate Buy” from the four analysts that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $22.00.

Several research analysts recently weighed in on the stock. Roth Mkm restated a “buy” rating and set a $16.00 price target (up from $13.00) on shares of Joint in a report on Friday, May 3rd. TheStreet downgraded Joint from a “c-” rating to a “d” rating in a research note on Thursday, March 7th. B. Riley boosted their price objective on Joint from $12.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, May 6th. Finally, StockNews.com upgraded shares of Joint from a “hold” rating to a “buy” rating in a report on Monday, May 6th.

Hedge Funds Weigh In On Joint

Large investors have recently modified their holdings of the business. Ancora Advisors LLC boosted its holdings in Joint by 105.0% in the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock worth $1,296,000 after buying an additional 50,815 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Joint by 5.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after acquiring an additional 837 shares in the last quarter. First Foundation Advisors boosted its holdings in shares of Joint by 18.8% in the first quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock worth $2,733,000 after acquiring an additional 33,104 shares during the period. Russell Investments Group Ltd. grew its position in shares of Joint by 8.9% in the first quarter. Russell Investments Group Ltd. now owns 90,147 shares of the company’s stock valued at $1,177,000 after purchasing an additional 7,375 shares in the last quarter. Finally, JCP Investment Management LLC grew its position in shares of Joint by 15.3% in the first quarter. JCP Investment Management LLC now owns 112,800 shares of the company’s stock valued at $1,473,000 after purchasing an additional 15,000 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Joint Stock Down 6.1 %

JYNT stock opened at $13.20 on Tuesday. The stock’s 50 day moving average is $14.85 and its 200-day moving average is $12.10. Joint has a twelve month low of $7.31 and a twelve month high of $17.82. The firm has a market capitalization of $197.60 million, a PE ratio of -17.60 and a beta of 1.60.

Joint (NASDAQ:JYNT) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.09. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The business had revenue of $29.72 million for the quarter, compared to analysts’ expectations of $29.17 million. On average, equities research analysts anticipate that Joint will post 0.2 earnings per share for the current fiscal year.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.